S&P 500 Ends Week Lower After Volatile Trading | Closing Bell

Watch on YouTube ↗  |  January 23, 2026 at 22:50  |  10:14  |  Bloomberg Markets
Speakers
Romaine Bostick — Anchor, Bloomberg
Carol Massar — Anchor, Bloomberg
Katie Greifeld — Anchor, Bloomberg

Summary

U.S. stocks finished mixed Friday and mostly lower for the week after volatile trading, with small caps and mid-caps underperforming. Investors are focused on upcoming big-tech earnings and the Fed meeting. Single-stock news included an upgrade-led Fortinet rally, CSX and Alaska Air results, Intel's plunge, Apple's extended losing streak, and syringe makers falling on oral Wegovy cannibalization fears. A major winter storm also disrupted travel and raised grid concerns.

  • S&P 500 finished slightly higher Friday but lower for the week; Russell 2000 and mid-caps underperformed.
  • Investors are focused on upcoming big-tech earnings and the Fed meeting.
  • Fortinet rallied after a TD Cowen upgrade; CSX and Alaska Air moved on earnings and guidance.
  • Intel plunged on a weak forecast and manufacturing problems.
  • Apple extended its weekly losing streak ahead of earnings, with iPhone and Siri/AI strategy in focus.
  • Syringe makers Becton Dickinson and West Pharmaceutical fell on fears oral Wegovy could cannibalize injectables.
  • A major winter storm disrupted flights and raised concerns about power grid resilience.
  • Bond volatility spiked earlier in the week but eased into Friday.
Ideas
Romaine Bostick Anchor, Bloomberg 5:40
Watch Apple into earnings next week.
Apple has fallen for eight straight weeks, down about 12%, and heads into earnings next week. The key catalyst is whether the iPhone and the revamped Siri/AI strategy can reverse the negative momentum; if not, the losing streak could extend to a ninth week, the longest since 1993.
AAPL MED
Romaine Bostick Anchor, Bloomberg 6:25
Oral GLP-1 pills threaten syringe makers.
Positive commentary on Novo Nordisk's oral Wegovy pill is raising fears that patients will shift from injectable GLP-1s to pills, reducing demand for syringes and hitting syringe makers such as Becton Dickinson and West Pharmaceutical Services.
BDX WST MED
Up Next
4:21
Disappointing earnings season could drive contingent selling, says Ned Davis' Tim Hayes
CNBC · Jan 23
4:49
Tech Investor Dan Niles talks what to expect from Big Tech earnings
CNBC · Jan 23
4:24
Loss of intermediate tech momentum 'has been weathered really well', says Fairlead's Katie Stockton
CNBC · Jan 23
2:50:38
China's Acquisition Spree, Insane Montana Mansions, TikTok Deal, Intel Slips
TBPN · Jan 23
7:07
Former TikTok CEO Mayer Weighs In on US Deal, Disney and Warner Bros.
Bloomberg Markets · Jan 23

This Bloomberg Markets video, published January 23, 2026, features Romaine Bostick discussing AAPL, BDX, WST. 2 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Romaine Bostick  · Tickers: AAPL, BDX, WST